nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Timolol—CYP2C19—epilepsy syndrome	0.00235	0.23	CrCbGaD
Levobunolol—Timolol—CYP2D6—epilepsy syndrome	0.00174	0.171	CrCbGaD
Levobunolol—Carteolol—CYP2D6—epilepsy syndrome	0.00155	0.152	CrCbGaD
Levobunolol—Timolol—ABCB1—epilepsy syndrome	0.00124	0.122	CrCbGaD
Levobunolol—Nadolol—ABCB1—epilepsy syndrome	0.000988	0.0969	CrCbGaD
Levobunolol—Dizziness—Clobazam—epilepsy syndrome	0.000884	0.0012	CcSEcCtD
Levobunolol—Shock—Phenytoin—epilepsy syndrome	0.000884	0.0012	CcSEcCtD
Levobunolol—Dyspnoea—Diazepam—epilepsy syndrome	0.000883	0.0012	CcSEcCtD
Levobunolol—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000881	0.0012	CcSEcCtD
Levobunolol—Urticaria—Propofol—epilepsy syndrome	0.000879	0.0012	CcSEcCtD
Levobunolol—Shock—Oxcarbazepine—epilepsy syndrome	0.000879	0.0012	CcSEcCtD
Levobunolol—Ataxia—Topiramate—epilepsy syndrome	0.000879	0.0012	CcSEcCtD
Levobunolol—Hypotension—Zonisamide—epilepsy syndrome	0.000877	0.00119	CcSEcCtD
Levobunolol—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000876	0.00119	CcSEcCtD
Levobunolol—Nausea—Rufinamide—epilepsy syndrome	0.000871	0.00119	CcSEcCtD
Levobunolol—Pindolol—CYP2D6—epilepsy syndrome	0.00087	0.0853	CrCbGaD
Levobunolol—Confusional state—Carbamazepine—epilepsy syndrome	0.000864	0.00118	CcSEcCtD
Levobunolol—Chest pain—Lamotrigine—epilepsy syndrome	0.000864	0.00118	CcSEcCtD
Levobunolol—Headache—Lacosamide—epilepsy syndrome	0.000863	0.00117	CcSEcCtD
Levobunolol—Paraesthesia—Felbamate—epilepsy syndrome	0.000861	0.00117	CcSEcCtD
Levobunolol—Pain—Vigabatrin—epilepsy syndrome	0.00086	0.00117	CcSEcCtD
Levobunolol—Urticaria—Midazolam—epilepsy syndrome	0.00086	0.00117	CcSEcCtD
Levobunolol—Asthenia—Acetazolamide—epilepsy syndrome	0.000855	0.00116	CcSEcCtD
Levobunolol—Dyspnoea—Felbamate—epilepsy syndrome	0.000855	0.00116	CcSEcCtD
Levobunolol—Depression—Gabapentin—epilepsy syndrome	0.000853	0.00116	CcSEcCtD
Levobunolol—Bradycardia—Pregabalin—epilepsy syndrome	0.000853	0.00116	CcSEcCtD
Levobunolol—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.00085	0.00116	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Gabapentin—epilepsy syndrome	0.000849	0.00115	CcSEcCtD
Levobunolol—Pain—Diazepam—epilepsy syndrome	0.000847	0.00115	CcSEcCtD
Levobunolol—Hypotension—Clonazepam—epilepsy syndrome	0.000845	0.00115	CcSEcCtD
Levobunolol—Shock—Carbamazepine—epilepsy syndrome	0.000844	0.00115	CcSEcCtD
Levobunolol—Paraesthesia—Zonisamide—epilepsy syndrome	0.000842	0.00115	CcSEcCtD
Levobunolol—Hypotension—Phenytoin—epilepsy syndrome	0.000839	0.00114	CcSEcCtD
Levobunolol—Headache—Clobazam—epilepsy syndrome	0.000837	0.00114	CcSEcCtD
Levobunolol—Dyspnoea—Zonisamide—epilepsy syndrome	0.000836	0.00114	CcSEcCtD
Levobunolol—Confusional state—Lamotrigine—epilepsy syndrome	0.000835	0.00114	CcSEcCtD
Levobunolol—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000835	0.00114	CcSEcCtD
Levobunolol—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000832	0.00113	CcSEcCtD
Levobunolol—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000829	0.00113	CcSEcCtD
Levobunolol—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000828	0.00113	CcSEcCtD
Levobunolol—Urticaria—Fosphenytoin—epilepsy syndrome	0.00082	0.00112	CcSEcCtD
Levobunolol—Pain—Felbamate—epilepsy syndrome	0.00082	0.00112	CcSEcCtD
Levobunolol—Alopecia—Valproic Acid—epilepsy syndrome	0.000819	0.00111	CcSEcCtD
Levobunolol—Nausea—Lacosamide—epilepsy syndrome	0.000818	0.00111	CcSEcCtD
Levobunolol—Feeling abnormal—Diazepam—epilepsy syndrome	0.000816	0.00111	CcSEcCtD
Levobunolol—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000815	0.00111	CcSEcCtD
Levobunolol—Shock—Lamotrigine—epilepsy syndrome	0.000815	0.00111	CcSEcCtD
Levobunolol—Visual impairment—Pregabalin—epilepsy syndrome	0.000807	0.0011	CcSEcCtD
Levobunolol—Paraesthesia—Phenytoin—epilepsy syndrome	0.000807	0.0011	CcSEcCtD
Levobunolol—Dyspnoea—Clonazepam—epilepsy syndrome	0.000806	0.0011	CcSEcCtD
Levobunolol—Hypotension—Carbamazepine—epilepsy syndrome	0.000801	0.00109	CcSEcCtD
Levobunolol—Dyspnoea—Phenytoin—epilepsy syndrome	0.000801	0.00109	CcSEcCtD
Levobunolol—Urticaria—Vigabatrin—epilepsy syndrome	0.000799	0.00109	CcSEcCtD
Levobunolol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000798	0.00109	CcSEcCtD
Levobunolol—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000797	0.00108	CcSEcCtD
Levobunolol—Nausea—Clobazam—epilepsy syndrome	0.000794	0.00108	CcSEcCtD
Levobunolol—Asthenia—Propofol—epilepsy syndrome	0.000794	0.00108	CcSEcCtD
Levobunolol—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000792	0.00108	CcSEcCtD
Levobunolol—Feeling abnormal—Felbamate—epilepsy syndrome	0.00079	0.00107	CcSEcCtD
Levobunolol—Dizziness—Acetazolamide—epilepsy syndrome	0.000788	0.00107	CcSEcCtD
Levobunolol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000788	0.00107	CcSEcCtD
Levobunolol—Urticaria—Diazepam—epilepsy syndrome	0.000787	0.00107	CcSEcCtD
Levobunolol—Pruritus—Propofol—epilepsy syndrome	0.000783	0.00107	CcSEcCtD
Levobunolol—Bradycardia—Gabapentin—epilepsy syndrome	0.000782	0.00106	CcSEcCtD
Levobunolol—Asthenia—Midazolam—epilepsy syndrome	0.000777	0.00106	CcSEcCtD
Levobunolol—Pain—Clonazepam—epilepsy syndrome	0.000773	0.00105	CcSEcCtD
Levobunolol—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000773	0.00105	CcSEcCtD
Levobunolol—Paraesthesia—Carbamazepine—epilepsy syndrome	0.00077	0.00105	CcSEcCtD
Levobunolol—Asthenia—Levetiracetam—epilepsy syndrome	0.000767	0.00104	CcSEcCtD
Levobunolol—Pruritus—Midazolam—epilepsy syndrome	0.000766	0.00104	CcSEcCtD
Levobunolol—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000764	0.00104	CcSEcCtD
Levobunolol—Pain—Oxcarbazepine—epilepsy syndrome	0.000764	0.00104	CcSEcCtD
Levobunolol—Urticaria—Felbamate—epilepsy syndrome	0.000761	0.00104	CcSEcCtD
Levobunolol—Diarrhoea—Propofol—epilepsy syndrome	0.000757	0.00103	CcSEcCtD
Levobunolol—Pruritus—Levetiracetam—epilepsy syndrome	0.000757	0.00103	CcSEcCtD
Levobunolol—Arrhythmia—Pregabalin—epilepsy syndrome	0.000748	0.00102	CcSEcCtD
Levobunolol—Headache—Acetazolamide—epilepsy syndrome	0.000746	0.00102	CcSEcCtD
Levobunolol—Urticaria—Zonisamide—epilepsy syndrome	0.000745	0.00101	CcSEcCtD
Levobunolol—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000745	0.00101	CcSEcCtD
Levobunolol—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000744	0.00101	CcSEcCtD
Levobunolol—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000744	0.00101	CcSEcCtD
Levobunolol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000741	0.00101	CcSEcCtD
Levobunolol—Asthenia—Fosphenytoin—epilepsy syndrome	0.00074	0.00101	CcSEcCtD
Levobunolol—Visual impairment—Gabapentin—epilepsy syndrome	0.00074	0.00101	CcSEcCtD
Levobunolol—Alopecia—Pregabalin—epilepsy syndrome	0.00074	0.00101	CcSEcCtD
Levobunolol—Feeling abnormal—Phenytoin—epilepsy syndrome	0.00074	0.00101	CcSEcCtD
Levobunolol—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000739	0.00101	CcSEcCtD
Levobunolol—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000736	0.001	CcSEcCtD
Levobunolol—Pain—Carbamazepine—epilepsy syndrome	0.000733	0.000998	CcSEcCtD
Levobunolol—Dizziness—Propofol—epilepsy syndrome	0.000732	0.000996	CcSEcCtD
Levobunolol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000732	0.000995	CcSEcCtD
Levobunolol—Pruritus—Fosphenytoin—epilepsy syndrome	0.00073	0.000993	CcSEcCtD
Levobunolol—Hypersensitivity—Diazepam—epilepsy syndrome	0.00073	0.000993	CcSEcCtD
Levobunolol—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000726	0.000988	CcSEcCtD
Levobunolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000722	0.000982	CcSEcCtD
Levobunolol—Urticaria—Clonazepam—epilepsy syndrome	0.000718	0.000977	CcSEcCtD
Levobunolol—Depression—Topiramate—epilepsy syndrome	0.000718	0.000977	CcSEcCtD
Levobunolol—Dizziness—Midazolam—epilepsy syndrome	0.000716	0.000974	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000714	0.000971	CcSEcCtD
Levobunolol—Urticaria—Phenytoin—epilepsy syndrome	0.000714	0.000971	CcSEcCtD
Levobunolol—Palpitations—Valproic Acid—epilepsy syndrome	0.000713	0.00097	CcSEcCtD
Levobunolol—Pruritus—Vigabatrin—epilepsy syndrome	0.000712	0.000968	CcSEcCtD
Levobunolol—Asthenia—Diazepam—epilepsy syndrome	0.000711	0.000967	CcSEcCtD
Levobunolol—Urticaria—Oxcarbazepine—epilepsy syndrome	0.00071	0.000966	CcSEcCtD
Levobunolol—Pain—Lamotrigine—epilepsy syndrome	0.000709	0.000964	CcSEcCtD
Levobunolol—Nausea—Acetazolamide—epilepsy syndrome	0.000708	0.000963	CcSEcCtD
Levobunolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000707	0.000962	CcSEcCtD
Levobunolol—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000707	0.000961	CcSEcCtD
Levobunolol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000706	0.000961	CcSEcCtD
Levobunolol—Pruritus—Diazepam—epilepsy syndrome	0.000701	0.000953	CcSEcCtD
Levobunolol—Conjunctivitis—Topiramate—epilepsy syndrome	0.0007	0.000952	CcSEcCtD
Levobunolol—Headache—Propofol—epilepsy syndrome	0.000693	0.000943	CcSEcCtD
Levobunolol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000691	0.00094	CcSEcCtD
Levobunolol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000688	0.000936	CcSEcCtD
Levobunolol—Asthenia—Felbamate—epilepsy syndrome	0.000688	0.000936	CcSEcCtD
Levobunolol—Chest pain—Valproic Acid—epilepsy syndrome	0.000687	0.000934	CcSEcCtD
Levobunolol—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000683	0.000929	CcSEcCtD
Levobunolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000682	0.000928	CcSEcCtD
Levobunolol—Urticaria—Carbamazepine—epilepsy syndrome	0.000681	0.000927	CcSEcCtD
Levobunolol—Alopecia—Gabapentin—epilepsy syndrome	0.000679	0.000924	CcSEcCtD
Levobunolol—Headache—Midazolam—epilepsy syndrome	0.000678	0.000923	CcSEcCtD
Levobunolol—Pruritus—Felbamate—epilepsy syndrome	0.000678	0.000923	CcSEcCtD
Levobunolol—Diarrhoea—Diazepam—epilepsy syndrome	0.000678	0.000922	CcSEcCtD
Levobunolol—Asthenia—Zonisamide—epilepsy syndrome	0.000673	0.000916	CcSEcCtD
Levobunolol—Headache—Levetiracetam—epilepsy syndrome	0.00067	0.000911	CcSEcCtD
Levobunolol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000666	0.000906	CcSEcCtD
Levobunolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000665	0.000905	CcSEcCtD
Levobunolol—Confusional state—Valproic Acid—epilepsy syndrome	0.000664	0.000903	CcSEcCtD
Levobunolol—Pruritus—Zonisamide—epilepsy syndrome	0.000664	0.000903	CcSEcCtD
Levobunolol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000662	0.0009	CcSEcCtD
Levobunolol—Urticaria—Lamotrigine—epilepsy syndrome	0.000658	0.000896	CcSEcCtD
Levobunolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000658	0.000896	CcSEcCtD
Levobunolol—Bradycardia—Topiramate—epilepsy syndrome	0.000658	0.000895	CcSEcCtD
Levobunolol—Nausea—Propofol—epilepsy syndrome	0.000657	0.000894	CcSEcCtD
Levobunolol—Diarrhoea—Felbamate—epilepsy syndrome	0.000656	0.000892	CcSEcCtD
Levobunolol—Dizziness—Diazepam—epilepsy syndrome	0.000655	0.000891	CcSEcCtD
Levobunolol—Syncope—Pregabalin—epilepsy syndrome	0.000654	0.00089	CcSEcCtD
Levobunolol—Asthenia—Clonazepam—epilepsy syndrome	0.000649	0.000883	CcSEcCtD
Levobunolol—Headache—Fosphenytoin—epilepsy syndrome	0.000647	0.00088	CcSEcCtD
Levobunolol—Palpitations—Pregabalin—epilepsy syndrome	0.000645	0.000877	CcSEcCtD
Levobunolol—Asthenia—Phenytoin—epilepsy syndrome	0.000644	0.000877	CcSEcCtD
Levobunolol—Nausea—Midazolam—epilepsy syndrome	0.000643	0.000875	CcSEcCtD
Levobunolol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000642	0.000873	CcSEcCtD
Levobunolol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000641	0.000872	CcSEcCtD
Levobunolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000641	0.000872	CcSEcCtD
Levobunolol—Propranolol—CYP2C19—epilepsy syndrome	0.00064	0.0628	CrCbGaD
Levobunolol—Pruritus—Clonazepam—epilepsy syndrome	0.00064	0.00087	CcSEcCtD
Levobunolol—Pruritus—Phenytoin—epilepsy syndrome	0.000635	0.000865	CcSEcCtD
Levobunolol—Nausea—Levetiracetam—epilepsy syndrome	0.000635	0.000864	CcSEcCtD
Levobunolol—Dizziness—Felbamate—epilepsy syndrome	0.000634	0.000862	CcSEcCtD
Levobunolol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000632	0.00086	CcSEcCtD
Levobunolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000632	0.000859	CcSEcCtD
Levobunolol—Headache—Vigabatrin—epilepsy syndrome	0.00063	0.000857	CcSEcCtD
Levobunolol—Visual impairment—Topiramate—epilepsy syndrome	0.000623	0.000847	CcSEcCtD
Levobunolol—Chest pain—Pregabalin—epilepsy syndrome	0.000621	0.000845	CcSEcCtD
Levobunolol—Dizziness—Zonisamide—epilepsy syndrome	0.00062	0.000844	CcSEcCtD
Levobunolol—Headache—Diazepam—epilepsy syndrome	0.00062	0.000844	CcSEcCtD
Levobunolol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000619	0.000842	CcSEcCtD
Levobunolol—Hypotension—Valproic Acid—epilepsy syndrome	0.000615	0.000837	CcSEcCtD
Levobunolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000615	0.000837	CcSEcCtD
Levobunolol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000615	0.000836	CcSEcCtD
Levobunolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000613	0.000834	CcSEcCtD
Levobunolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000611	0.000832	CcSEcCtD
Levobunolol—Erythema multiforme—Topiramate—epilepsy syndrome	0.000611	0.000832	CcSEcCtD
Levobunolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.00061	0.000831	CcSEcCtD
Levobunolol—Pruritus—Carbamazepine—epilepsy syndrome	0.000607	0.000825	CcSEcCtD
Levobunolol—Headache—Felbamate—epilepsy syndrome	0.0006	0.000817	CcSEcCtD
Levobunolol—Confusional state—Pregabalin—epilepsy syndrome	0.0006	0.000817	CcSEcCtD
Levobunolol—Syncope—Gabapentin—epilepsy syndrome	0.0006	0.000816	CcSEcCtD
Levobunolol—Dizziness—Clonazepam—epilepsy syndrome	0.000598	0.000814	CcSEcCtD
Levobunolol—Nausea—Vigabatrin—epilepsy syndrome	0.000598	0.000813	CcSEcCtD
Levobunolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000595	0.000809	CcSEcCtD
Levobunolol—Dizziness—Phenytoin—epilepsy syndrome	0.000594	0.000808	CcSEcCtD
Levobunolol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000591	0.000804	CcSEcCtD
Levobunolol—Palpitations—Gabapentin—epilepsy syndrome	0.000591	0.000804	CcSEcCtD
Levobunolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000591	0.000804	CcSEcCtD
Levobunolol—Nausea—Diazepam—epilepsy syndrome	0.000588	0.0008	CcSEcCtD
Levobunolol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000588	0.0008	CcSEcCtD
Levobunolol—Headache—Zonisamide—epilepsy syndrome	0.000588	0.0008	CcSEcCtD
Levobunolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000587	0.000799	CcSEcCtD
Levobunolol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000587	0.000798	CcSEcCtD
Levobunolol—Pruritus—Lamotrigine—epilepsy syndrome	0.000586	0.000798	CcSEcCtD
Levobunolol—Shock—Pregabalin—epilepsy syndrome	0.000586	0.000797	CcSEcCtD
Levobunolol—Alopecia—Topiramate—epilepsy syndrome	0.000571	0.000777	CcSEcCtD
Levobunolol—Chest pain—Gabapentin—epilepsy syndrome	0.000569	0.000775	CcSEcCtD
Levobunolol—Nausea—Felbamate—epilepsy syndrome	0.000569	0.000775	CcSEcCtD
Levobunolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000567	0.000771	CcSEcCtD
Levobunolol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000567	0.000771	CcSEcCtD
Levobunolol—Headache—Clonazepam—epilepsy syndrome	0.000566	0.000771	CcSEcCtD
Levobunolol—Pain—Valproic Acid—epilepsy syndrome	0.000563	0.000766	CcSEcCtD
Levobunolol—Headache—Phenytoin—epilepsy syndrome	0.000563	0.000766	CcSEcCtD
Levobunolol—Headache—Oxcarbazepine—epilepsy syndrome	0.00056	0.000762	CcSEcCtD
Levobunolol—Nausea—Zonisamide—epilepsy syndrome	0.000557	0.000758	CcSEcCtD
Levobunolol—Hypotension—Pregabalin—epilepsy syndrome	0.000556	0.000757	CcSEcCtD
Levobunolol—Confusional state—Gabapentin—epilepsy syndrome	0.00055	0.000749	CcSEcCtD
Levobunolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000548	0.000745	CcSEcCtD
Levobunolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000543	0.000738	CcSEcCtD
Levobunolol—Nausea—Clonazepam—epilepsy syndrome	0.000537	0.000731	CcSEcCtD
Levobunolol—Headache—Carbamazepine—epilepsy syndrome	0.000537	0.000731	CcSEcCtD
Levobunolol—Shock—Gabapentin—epilepsy syndrome	0.000537	0.000731	CcSEcCtD
Levobunolol—Paraesthesia—Pregabalin—epilepsy syndrome	0.000535	0.000727	CcSEcCtD
Levobunolol—Nausea—Phenytoin—epilepsy syndrome	0.000534	0.000726	CcSEcCtD
Levobunolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000531	0.000722	CcSEcCtD
Levobunolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000531	0.000722	CcSEcCtD
Levobunolol—Urticaria—Valproic Acid—epilepsy syndrome	0.000523	0.000712	CcSEcCtD
Levobunolol—Headache—Lamotrigine—epilepsy syndrome	0.000519	0.000706	CcSEcCtD
Levobunolol—Hypotension—Gabapentin—epilepsy syndrome	0.00051	0.000694	CcSEcCtD
Levobunolol—Nausea—Carbamazepine—epilepsy syndrome	0.000509	0.000693	CcSEcCtD
Levobunolol—Pain—Pregabalin—epilepsy syndrome	0.000509	0.000693	CcSEcCtD
Levobunolol—Syncope—Topiramate—epilepsy syndrome	0.000505	0.000687	CcSEcCtD
Levobunolol—Palpitations—Topiramate—epilepsy syndrome	0.000497	0.000677	CcSEcCtD
Levobunolol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000495	0.000673	CcSEcCtD
Levobunolol—Nausea—Lamotrigine—epilepsy syndrome	0.000492	0.00067	CcSEcCtD
Levobunolol—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000491	0.000667	CcSEcCtD
Levobunolol—Paraesthesia—Gabapentin—epilepsy syndrome	0.00049	0.000667	CcSEcCtD
Levobunolol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000487	0.000662	CcSEcCtD
Levobunolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000485	0.00066	CcSEcCtD
Levobunolol—Chest pain—Topiramate—epilepsy syndrome	0.000479	0.000652	CcSEcCtD
Levobunolol—Propranolol—CYP2D6—epilepsy syndrome	0.000475	0.0465	CrCbGaD
Levobunolol—Urticaria—Pregabalin—epilepsy syndrome	0.000473	0.000643	CcSEcCtD
Levobunolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000472	0.000643	CcSEcCtD
Levobunolol—Pain—Gabapentin—epilepsy syndrome	0.000467	0.000635	CcSEcCtD
Levobunolol—Pruritus—Valproic Acid—epilepsy syndrome	0.000466	0.000634	CcSEcCtD
Levobunolol—Confusional state—Topiramate—epilepsy syndrome	0.000463	0.00063	CcSEcCtD
Levobunolol—Shock—Topiramate—epilepsy syndrome	0.000452	0.000615	CcSEcCtD
Levobunolol—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000451	0.000613	CcSEcCtD
Levobunolol—Feeling abnormal—Gabapentin—epilepsy syndrome	0.00045	0.000612	CcSEcCtD
Levobunolol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000439	0.000597	CcSEcCtD
Levobunolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000435	0.000592	CcSEcCtD
Levobunolol—Urticaria—Gabapentin—epilepsy syndrome	0.000434	0.00059	CcSEcCtD
Levobunolol—Hypotension—Topiramate—epilepsy syndrome	0.000429	0.000584	CcSEcCtD
Levobunolol—Asthenia—Pregabalin—epilepsy syndrome	0.000427	0.000581	CcSEcCtD
Levobunolol—Pruritus—Pregabalin—epilepsy syndrome	0.000421	0.000573	CcSEcCtD
Levobunolol—Headache—Valproic Acid—epilepsy syndrome	0.000412	0.000561	CcSEcCtD
Levobunolol—Paraesthesia—Topiramate—epilepsy syndrome	0.000412	0.000561	CcSEcCtD
Levobunolol—Dyspnoea—Topiramate—epilepsy syndrome	0.000409	0.000557	CcSEcCtD
Levobunolol—Diarrhoea—Pregabalin—epilepsy syndrome	0.000407	0.000554	CcSEcCtD
Levobunolol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000402	0.000547	CcSEcCtD
Levobunolol—Dizziness—Pregabalin—epilepsy syndrome	0.000394	0.000536	CcSEcCtD
Levobunolol—Pain—Topiramate—epilepsy syndrome	0.000393	0.000534	CcSEcCtD
Levobunolol—Asthenia—Gabapentin—epilepsy syndrome	0.000392	0.000533	CcSEcCtD
Levobunolol—Nausea—Valproic Acid—epilepsy syndrome	0.000391	0.000532	CcSEcCtD
Levobunolol—Pruritus—Gabapentin—epilepsy syndrome	0.000386	0.000525	CcSEcCtD
Levobunolol—Feeling abnormal—Topiramate—epilepsy syndrome	0.000378	0.000515	CcSEcCtD
Levobunolol—Diarrhoea—Gabapentin—epilepsy syndrome	0.000373	0.000508	CcSEcCtD
Levobunolol—Headache—Pregabalin—epilepsy syndrome	0.000373	0.000507	CcSEcCtD
Levobunolol—Urticaria—Topiramate—epilepsy syndrome	0.000365	0.000496	CcSEcCtD
Levobunolol—Dizziness—Gabapentin—epilepsy syndrome	0.000361	0.000491	CcSEcCtD
Levobunolol—Nausea—Pregabalin—epilepsy syndrome	0.000354	0.000481	CcSEcCtD
Levobunolol—Headache—Gabapentin—epilepsy syndrome	0.000342	0.000465	CcSEcCtD
Levobunolol—Propranolol—ABCB1—epilepsy syndrome	0.000339	0.0332	CrCbGaD
Levobunolol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000338	0.00046	CcSEcCtD
Levobunolol—Asthenia—Topiramate—epilepsy syndrome	0.000329	0.000448	CcSEcCtD
Levobunolol—Pruritus—Topiramate—epilepsy syndrome	0.000325	0.000442	CcSEcCtD
Levobunolol—Nausea—Gabapentin—epilepsy syndrome	0.000324	0.000441	CcSEcCtD
Levobunolol—Diarrhoea—Topiramate—epilepsy syndrome	0.000314	0.000427	CcSEcCtD
Levobunolol—Dizziness—Topiramate—epilepsy syndrome	0.000304	0.000413	CcSEcCtD
Levobunolol—Headache—Topiramate—epilepsy syndrome	0.000288	0.000391	CcSEcCtD
Levobunolol—Nausea—Topiramate—epilepsy syndrome	0.000273	0.000371	CcSEcCtD
Levobunolol—ADRB1—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000131	0.000513	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000131	0.000513	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SSTR3—epilepsy syndrome	0.000131	0.000512	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL3—epilepsy syndrome	0.000128	0.000504	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CRH—epilepsy syndrome	0.000128	0.000504	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—OXT—epilepsy syndrome	0.000128	0.000504	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000128	0.000504	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPY2R—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR9—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR8—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SSTR1—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—SST—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000128	0.000502	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000128	0.000501	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM3—epilepsy syndrome	0.000125	0.000493	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM4—epilepsy syndrome	0.000125	0.000493	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR9—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SSTR1—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR8—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPY2R—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000125	0.000491	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SSTR2—epilepsy syndrome	0.000123	0.000483	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DUSP4—epilepsy syndrome	0.000123	0.000483	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000123	0.000482	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000123	0.000482	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM3—epilepsy syndrome	0.000123	0.000482	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM4—epilepsy syndrome	0.000123	0.000482	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000121	0.000473	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SSTR2—epilepsy syndrome	0.000121	0.000473	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DUSP4—epilepsy syndrome	0.000121	0.000473	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.00012	0.000472	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.00012	0.000472	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.00012	0.000472	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM8—epilepsy syndrome	0.000119	0.000467	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PGF—epilepsy syndrome	0.000119	0.000467	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCR2—epilepsy syndrome	0.000119	0.000466	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SST—epilepsy syndrome	0.000119	0.000466	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000118	0.000463	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000118	0.000462	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000118	0.000461	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—POMC—epilepsy syndrome	0.000116	0.000457	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM8—epilepsy syndrome	0.000116	0.000457	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PGF—epilepsy syndrome	0.000116	0.000457	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000116	0.000456	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCR2—epilepsy syndrome	0.000116	0.000456	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SST—epilepsy syndrome	0.000116	0.000456	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000115	0.000452	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000114	0.000447	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—POMC—epilepsy syndrome	0.000114	0.000447	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000114	0.000446	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000113	0.000445	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000113	0.000445	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000112	0.00044	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000112	0.000438	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000112	0.000438	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL2—epilepsy syndrome	0.000111	0.000438	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—OPRD1—epilepsy syndrome	0.000111	0.000436	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNAO1—epilepsy syndrome	0.000111	0.000436	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	0.00011	0.000431	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CNR1—epilepsy syndrome	0.00011	0.00043	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000109	0.000428	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000109	0.000428	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000109	0.000428	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000109	0.000427	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	0.000109	0.000427	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	0.000109	0.000427	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	0.000109	0.000427	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	0.000107	0.000421	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000107	0.000419	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000107	0.000419	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	0.000106	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	0.000106	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	0.000106	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	0.000106	0.000418	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	0.000105	0.00041	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000104	0.000407	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000102	0.000402	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	0.000102	0.000402	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	0.000102	0.000402	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000102	0.0004	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000101	0.000398	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000101	0.000397	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	0.000101	0.000397	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	0.000101	0.000397	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	0.0001	0.000393	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	0.0001	0.000393	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	0.0001	0.000393	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	9.96e-05	0.000391	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	9.91e-05	0.000389	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	9.9e-05	0.000388	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	9.9e-05	0.000388	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	9.9e-05	0.000388	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	9.7e-05	0.000381	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	9.69e-05	0.00038	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	9.51e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	9.51e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	9.51e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	9.49e-05	0.000372	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	9.3e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	9.3e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	9.3e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	9.29e-05	0.000365	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	9.25e-05	0.000363	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	9.09e-05	0.000357	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	9.05e-05	0.000355	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	9e-05	0.000353	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	8.87e-05	0.000348	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	8.8e-05	0.000345	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	8.73e-05	0.000343	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	8.68e-05	0.000341	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	8.54e-05	0.000335	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	8.42e-05	0.000331	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	8.25e-05	0.000324	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.24e-05	0.000323	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	8.24e-05	0.000323	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	8.07e-05	0.000317	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.06e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	8.04e-05	0.000315	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.04e-05	0.000315	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	7.86e-05	0.000309	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	7.86e-05	0.000309	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	7.82e-05	0.000307	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	7.75e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	7.75e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	7.75e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	7.75e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	7.75e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	7.65e-05	0.0003	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	7.65e-05	0.0003	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	7.58e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	7.58e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	7.58e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	7.58e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	7.58e-05	0.000298	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	7.49e-05	0.000294	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	7.48e-05	0.000294	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	7.32e-05	0.000287	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.23e-05	0.000284	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	7.21e-05	0.000283	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	7.21e-05	0.000283	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	7.1e-05	0.000279	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.07e-05	0.000277	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	7.05e-05	0.000277	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	7.05e-05	0.000277	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	7.01e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	7.01e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	7.01e-05	0.000275	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	6.95e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	6.95e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.86e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	6.86e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	6.86e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	6.86e-05	0.000269	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	6.83e-05	0.000268	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	6.8e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	6.71e-05	0.000263	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	6.68e-05	0.000262	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	6.59e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.59e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	6.58e-05	0.000258	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.56e-05	0.000258	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.54e-05	0.000257	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	6.47e-05	0.000254	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	6.47e-05	0.000254	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	6.45e-05	0.000253	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	6.45e-05	0.000253	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	6.45e-05	0.000253	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	6.44e-05	0.000253	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	6.42e-05	0.000252	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	6.39e-05	0.000251	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	6.33e-05	0.000248	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	6.33e-05	0.000248	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	6.31e-05	0.000248	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	6.31e-05	0.000248	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	6.18e-05	0.000242	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	6.13e-05	0.000241	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	6.02e-05	0.000236	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	6e-05	0.000235	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	5.98e-05	0.000235	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	5.88e-05	0.000231	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	5.88e-05	0.000231	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	5.85e-05	0.00023	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	5.85e-05	0.00023	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	5.75e-05	0.000226	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	5.72e-05	0.000225	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	5.56e-05	0.000218	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	5.5e-05	0.000216	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	5.49e-05	0.000215	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	5.44e-05	0.000213	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	5.38e-05	0.000211	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	5.37e-05	0.000211	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	5.31e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	5.2e-05	0.000204	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	5.03e-05	0.000197	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	4.92e-05	0.000193	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	4.89e-05	0.000192	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	4.87e-05	0.000191	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	4.86e-05	0.000191	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	4.78e-05	0.000188	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	4.76e-05	0.000187	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	4.75e-05	0.000187	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.7e-05	0.000184	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	4.64e-05	0.000182	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.6e-05	0.00018	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	4.54e-05	0.000178	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	4.52e-05	0.000177	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	4.42e-05	0.000174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	4.42e-05	0.000173	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	4.33e-05	0.00017	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	4.2e-05	0.000165	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	4.2e-05	0.000165	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	4.11e-05	0.000161	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	4.11e-05	0.000161	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	4.1e-05	0.000161	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	4.03e-05	0.000158	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	4.02e-05	0.000158	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	3.94e-05	0.000155	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	3.88e-05	0.000152	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	3.86e-05	0.000152	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	3.79e-05	0.000149	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	3.78e-05	0.000148	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	3.53e-05	0.000139	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	3.46e-05	0.000136	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	3.45e-05	0.000136	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	3.38e-05	0.000133	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	3.12e-05	0.000123	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	3.05e-05	0.00012	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	2.9e-05	0.000114	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	2.84e-05	0.000112	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	2.84e-05	0.000111	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	2.78e-05	0.000109	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.64e-05	0.000104	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	2.61e-05	0.000103	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.58e-05	0.000101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	2.56e-05	0.0001	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	2.54e-05	9.97e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	2.48e-05	9.75e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	2.47e-05	9.7e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	2.42e-05	9.49e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.4e-05	9.41e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	2.34e-05	9.2e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.28e-05	8.94e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	2.23e-05	8.75e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.22e-05	8.71e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.17e-05	8.52e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-05	5.56e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.38e-05	5.43e-05	CbGpPWpGaD
